15-72350574-C-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000520.6(HEXA):c.749G>A(p.Gly250Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G250S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000520.6 missense
Scores
Clinical Significance
Conservation
Publications
- Tay-Sachs diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HEXA | NM_000520.6 | c.749G>A | p.Gly250Asp | missense_variant | Exon 7 of 14 | ENST00000268097.10 | NP_000511.2 | |
| HEXA | NM_001318825.2 | c.782G>A | p.Gly261Asp | missense_variant | Exon 7 of 14 | NP_001305754.1 | ||
| HEXA | NR_134869.3 | n.791G>A | non_coding_transcript_exon_variant | Exon 7 of 11 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Tay-Sachs disease Pathogenic:3
Variant summary: HEXA c.749G>A (p.Gly250Asp) results in a non-conservative amino acid change located in the Glycoside hydrolase family 20, catalytic domain (IPR015883) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251484 control chromosomes. c.749G>A has been reported in the literature in multiple homozygous individuals affected with Tay-Sachs Disease (e.g. Trop_1992). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <10% of normal enzyme activity in vitro (e.g. Trop_1992). The following publication has been ascertained in the context of this evaluation (PMID: 1301189). ClinVar contains an entry for this variant (Variation ID: 3902). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This variant was identified as homozygous._x000D_ Criteria applied: PM3, PM5, PM2_SUP, PP3 -
Tay-sachs disease, juvenile Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at